Mylan Says FDA Probe Clears W.Va. Facility Under Fire

Drug Industry Daily
A A
Mylan provided a brief update of an FDA for-cause investigation of its Morgantown, West Virginia, plant on its earnings call and discussed its biologics plans.

To View This Article:

Login

Subscribe To Drug Industry Daily